BSc2118 is a potent proteasome inhibitor. BSc2118 shows significant antimyeloma activity and may be considered as a promising agent in cancer drug development. BSc2118 is also a promising new candidate for stroke therapy, which may in addition alleviate recombinant tissue-plasminogen activator-induced brain toxicity.
Molecular Weight:
533.66
CAS Number:
[863924-64-5]
Formula:
C28H43N3O7
Target:
Others
T68513
* VAT and and shipping costs not included. Errors and price changes excepted
